We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
TTK Healthcare Limited engages in the pharmaceutical, consumer product, medical device, protective device, and food businesses in India and internationally. The company's Pharmaceuticals segment deals in herbal and allopathic formulations for human and veterinary uses. It offers pharmaceutical products for various therapeutic segments, such as gynecology, infertility, respiratory, orthopedics, cardiology, and general health, as well as provides food supplements. Its Consumer Products segment is involved in marketing and distribution of Woodwards's Gripe Water, EVA range of cosmetics, Good Home range of scrubbers, air fresheners, etc. The company's Medical Devices segment manufactures and distributes artificial heart valves; and develops orthopedic implants and instruments. Its Protective Devices segment manufactures and markets male contraceptives and other allied products. The company's Foods segment manufactures and markets food products, including potato and cereal based pellets. Its Others segment prints and publishes maps and atlases. The company was incorporated in 1958 and is headquartered in Chennai, India. TTK Healthcare Limited is a subsidiary of T T Krishnamachari & Co., Ltd.
TODAY'S HIGH
829
TODAY'S LOW
790
52 WEEK HIGH
934
52 WEEK LOW
622.35
% of Shares Held by
All Insider
76.65%
% of Shares Held by
Institutions
7.62%
% of Float Held by
Institutions
32.62%
Number of Institutions
Holding Shares
4
MARKET CAP
1150.20 Cr.
ETERPRISE VALUE
860.30 Cr.
NO. OF SHARES
1.41 Cr.
BOOK VALUE
233.42
DIV. YIELD
10%
DEBT
22.21 Cr.
GROSS PROFIT
317.74 Cr.
CASH
273.50 Cr.
REVENUE
599.23 Cr.
REVENUE/SHARE
424.053
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Investments | -40.50 Cr. | -93.60 Cr. | -10.06 Cr. | 6.48 Cr. |
| Change To Liabilities | 13 Cr. | 11.19 Cr. | 15.49 Cr. | -13.61 Cr. |
| Total cashflows from Investing Activities | -30.54 Cr. | -77.23 Cr. | -13.29 Cr. | 9.65 Cr. |
| Net Borrowings | 3.30 Cr. | -10.69 Cr. | 1.62 Cr. | -18.83 Cr. |
| Total Cash from Financing Activities | -9.13 Cr. | -17.15 Cr. | -10.16 Cr. | -30.72 Cr. |
| Other Liabilities | 8.85 Cr. | 12.76 Cr. | 1.39 Cr. | 22.16 Cr. |
| Total Assets | 0 | 0 | 0 | 0 |
| Net Income | 41.58 Cr. | 46.44 Cr. | 12.31 Cr. | 24.37 Cr. |
| Change in Cash | 5.30 Cr. | 2.02 Cr. | -3.62 Cr. | -3.76 Cr. |
| Effect of Exchange Rate | 0 | 0 | 0 | 0 |
| Total Cash from Operating Activities | 44.99 Cr. | 96.42 Cr. | 19.83 Cr. | 17.30 Cr. |
| Depreciation | 13.18 Cr. | 13.62 Cr. | 14.27 Cr. | 14.32 Cr. |
| Other Cashflows from Investing Activities | 13.87 Cr. | 18.03 Cr. | 8.30 Cr. | 7.47 Cr. |
| Dividends Paid | -8.47 Cr. | -4.23 Cr. | -7.06 Cr. | -7.06 Cr. |
| Change to Inventory | -16.12 Cr. | 1.34 Cr. | -16.33 Cr. | -2.41 Cr. |
| Change to Account Receivables | -9.60 Cr. | 15.87 Cr. | 3.47 Cr. | -24.90 Cr. |
| Other Cashflows from Financing Activities | -3.96 Cr. | -2.22 Cr. | -4.72 Cr. | -4.83 Cr. |
| Change to Net Income | -5.92 Cr. | -4.91 Cr. | -10.88 Cr. | -2.96 Cr. |
| Capital Expenditures | -6.49 Cr. | -1.73 Cr. | -12.23 Cr. | -4.32 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Research Development | None | None | None | None |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | 24.83 Cr. | 37.05 Cr. | 19.42 Cr. | 39.25 Cr. |
| Minority Interest | None | None | None | None |
| Net Income | 9.25 Cr. | 21.31 Cr. | 14.51 Cr. | 35.86 Cr. |
| Selling General Administrative | 102.84 Cr. | 241.75 Cr. | 235.01 Cr. | 130.80 Cr. |
| Gross Profit | 317.74 Cr. | 372.46 Cr. | 374.19 Cr. | 365.29 Cr. |
| Ebit | 9.25 Cr. | 21.31 Cr. | 14.51 Cr. | 35.86 Cr. |
| Operating Income | 9.25 Cr. | 21.31 Cr. | 14.51 Cr. | 35.86 Cr. |
| Other Operating Expenses | 193.06 Cr. | 95.40 Cr. | 109.78 Cr. | 184.05 Cr. |
| Interest Expense | -3.23 Cr. | -2.10 Cr. | -3.14 Cr. | -3.25 Cr. |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | 6.32 Cr. | -9.38 Cr. | 7.10 Cr. | 14.88 Cr. |
| Total Revenue | 599.23 Cr. | 636.52 Cr. | 645.76 Cr. | 627.88 Cr. |
| Total Operating Expenses | 589.98 Cr. | 615.21 Cr. | 631.25 Cr. | 592.01 Cr. |
| Cost of Revenue | 281.49 Cr. | 264.06 Cr. | 271.56 Cr. | 262.59 Cr. |
| Total Other Income Expense Net | 15.58 Cr. | 15.73 Cr. | 4.91 Cr. | 3.38 Cr. |
| Discontinued Operations | 23.07 Cr. | 23.07 Cr. | 23.07 Cr. | 23.07 Cr. |
| Net Income from Continuous Ops. | 18.51 Cr. | 46.44 Cr. | 12.31 Cr. | 24.37 Cr. |
| Net Income Applicable to Common Shares | 41.58 Cr. | 46.44 Cr. | 12.31 Cr. | 24.37 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Intangible Assets | 8.63 Lakhs | 15.35 Lakhs | 23.70 Lakhs | 33.56 Lakhs |
| Capital Surplus | 0 | 9.82 Cr. | 9.82 Cr. | 9.82 Cr. |
| Total Liabilities | 228.91 Cr. | 199.62 Cr. | 182.21 Cr. | 164.38 Cr. |
| Stock Holder Equity | 329.63 Cr. | 294.64 Cr. | 248.99 Cr. | 251.42 Cr. |
| Minority Interest | 0 | 0 | 0 | 0 |
| Other Liabilities | 91.88 Cr. | 28.86 Cr. | 27 Cr. | 26.52 Cr. |
| Total Assets | 558.54 Cr. | 494.27 Cr. | 431.20 Cr. | 415.81 Cr. |
| Common Stock | 14.13 Cr. | 14.13 Cr. | 14.13 Cr. | 14.13 Cr. |
| Retained Earnings | 0 | 246.19 Cr. | 204.93 Cr. | 203.07 Cr. |
| Other Liabilities | 7.04 Cr. | 9.70 Cr. | 9.44 Cr. | 6.97 Cr. |
| Good Will | 0 | 0 | 0 | 0 |
| Treasury Stock | 315.50 Cr. | 24.50 Cr. | 20.10 Cr. | 24.39 Cr. |
| Other Assets | 14.44 Cr. | 20.44 Cr. | 27.33 Cr. | 31.94 Cr. |
| Cash | 273.50 Cr. | 9.55 Cr. | 7.52 Cr. | 11.15 Cr. |
| Current Liabilities | 220.53 Cr. | 188.76 Cr. | 171.50 Cr. | 157.07 Cr. |
| Long Term Asset Charges | 7.30 Cr. | 6.45 Cr. | 4.16 Cr. | 4.87 Cr. |
| Short Long Term Debt | 0 | 0 | 0 | 0 |
| Other Stockholder Equity | 315.50 Cr. | 24.50 Cr. | 20.10 Cr. | 24.39 Cr. |
| Property Plant Equipment | 80.37 Cr. | 85.63 Cr. | 97.18 Cr. | 98.76 Cr. |
| Total Cur. Assets | 448.51 Cr. | 374.87 Cr. | 297.70 Cr. | 271.71 Cr. |
| Long Term Investments | 15.13 Cr. | 13.16 Cr. | 8.75 Cr. | 13.04 Cr. |
| Net Tangible Assets | 329.54 Cr. | 294.49 Cr. | 248.75 Cr. | 251.09 Cr. |
| Short Term Investments | 0 | 217.44 Cr. | 122.86 Cr. | 112.53 Cr. |
| Net Receivables | 53.58 Cr. | 63.98 Cr. | 82.15 Cr. | 83.17 Cr. |
| Long Term Debt | 0 | 0 | 0 | 0 |
| Inventory | 78.92 Cr. | 70.30 Cr. | 71.64 Cr. | 55.30 Cr. |
| Accounts Payable | 103.45 Cr. | 97.60 Cr. | 86.50 Cr. | 72.71 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account